Allergan to Build on Body Contouring Portfolio with Latest Soliton Acquisition
The Soliton acquisition adds RESONIC technology platform for improvement in appearance of cellulite, tattoo removal, and fibrotic scars.
The Soliton acquisition adds RESONIC technology platform for improvement in appearance of cellulite, tattoo removal, and fibrotic scars.
The initial launch of the RESONIC brand for tattoo and cellulite indications is expected in Q2 of 2021.
For patients considering or undergoing plastic and reconstructive surgery procedures, using social media to gather information and answer questions can enhance patient empowerment—potentially leading to increased autonomy and better decision-making, reports a study in the April issue of Plastic and Reconstructive Surgery.